Why Are So Many Young People Getting Cancer? It ’s Complicated
Just this month, two young, high-profile public figures announced that they have cancer. First, Olivia Munn, 43, disclosed that she was treated for breast cancer after catching it early. Days later, Kate Middleton, 42, announced she has been receiving treatment for an unspecified form of cancer.
[time-brightcove not-tgx=”true”]
Their diagnoses spotlight a troubling trend: both in the U.S. and around the world, cancer diagnoses are growing more common among adults younger than 50. By 2030, one recent study estimated, the number of these early-onset cancer diagnoses could increase by roughly 30% worldwide&md...
Source: TIME: Health - March 26, 2024 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate Source Type: news
Incredible map shows world's 'fattest countries' - tiny island the most obese
The United Kingdom features on the map - but the world's top ranking countries all appear to have one thing in common. (Source: Daily Express - Health)
Source: Daily Express - Health - March 26, 2024 Category: Consumer Health News Source Type: news
Childhood Adenotonsillectomy Does Not Increase Overweight Risk in Adulthood
TUESDAY, March 26, 2024 -- Adenotonsillectomy (AT), the primary pediatric obstructive sleep apnea (OSA) treatment, is not associated with an increased risk for being overweight in adulthood, according to a study published online Feb. 28 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 26, 2024 Category: Pharmaceuticals Source Type: news
Viking Therapeutics' Experimental Tablet Cuts Weight in Small Study Viking Therapeutics' Experimental Tablet Cuts Weight in Small Study
Viking Therapeutics ' experimental tablet helped reduce weight by as much as 3.3% in obese patients during a small early-stage study, meeting Wall Street expectations, and...Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 26, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Amazon hopes anti-obesity drug demand will boost pharmacy business
Ecommerce giant says it stands to generate ‘a lot of revenue’ from Eli Lilly’s Zepbound and similar treatments (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - March 26, 2024 Category: Pharmaceuticals Source Type: news
Incredible little-known 'superfood' berry could slash diabetes and obesity risk
These small orange berries can be found on shrubs in Europe and Asia, and can be consumed in a handy supplement form. (Source: Daily Express - Health)
Source: Daily Express - Health - March 25, 2024 Category: Consumer Health News Source Type: news
Novo Nordisk to buy Cardior Pharma for up to $1 billion
Novo Nordisk A/S bought Cardior Pharmaceuticals for $1 billion to enhance cardiovascular treatments. Cardior's microRNA-targeting therapies aim to improve heart function, aligning with Novo's focus on diabetes and obesity history. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 25, 2024 Category: Pharmaceuticals Source Type: news
Can cardiac PET/CT ‘revolutionize’ heart care?
PET/CT is poised to become a key tool for imaging the coronary arteries – a clinical imaging exam that can reveal early warning signs of fatal conditions when patients present with symptoms of chest pain, experts say.
The “hybrid” scan – which combines molecular PET and anatomical CT images – may have its highest potential in visualizing early signs of so-called “perfusion deficits” (regions of obstructed blood flow), said Marcelo Di Carli, MD, a professor of radiology and medicine at Harvard Medical School, in a recent interview with AuntMinnie.com.
“[PET/CT] helps us differentiate a patient who has ches...
Source: AuntMinnie.com Headlines - March 25, 2024 Category: Radiology Authors: Will Morton Tags: Clinical News Subspecialties Molecular Imaging Cardiovascular Radiology Source Type: news
Patients Hate ‘Forever’ Drugs. Is Wegovy Different?
Most people, study after study shows, don’t take the medicines prescribed for them. But that resistance may be overcome by the blockbuster obesity drugs Wegovy and Zepbound. (Source: Reuters: Health)
Source: Reuters: Health - March 25, 2024 Category: Consumer Health News Source Type: news
Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
Two of the year’s biggest investment themes, artificial intelligence and anti-obesity drugs, are finally meeting up, as Novo Nordisk A/S NYSE: NVO and Nvidia Corp. NASDAQ: NVDA announced a partnership to develop supercomputers. In tandem with Nvidia’s developers’ conference in March, the Novo…#novonordiskasnyse #nvo #nvidiacorp #nvda #nvidia #denmark #novonordisk #elilillyco #lly #novonordisks (Source: Reuters: Health)
Source: Reuters: Health - March 24, 2024 Category: Consumer Health News Source Type: news
Patients Hate ‘Forever’ Drugs. Are Ozempic and Wegovy Different?
The new obesity drugs might be an exception to a chronic, deadly problem: the failure to stick with medication. (Source: NYT Health)
Source: NYT Health - March 24, 2024 Category: Consumer Health News Authors: Gina Kolata Tags: Semaglutide (Drug) Obesity Weight Drugs (Pharmaceuticals) Heart Diabetes Statins (Cholesterol-Lowering Drugs) Source Type: news
Weight-loss jabs could become the 'new statin' for heart treatment after US regulators approve the drug
It follows the results of a major trial which found the drug, known as semaglutide, could slash the risk of a heart attack or stroke in people with obesity by around 20 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - March 23, 2024 Category: Consumer Health News Source Type: news
Mar 22 2024 This Week in Cardiology Mar 22 2024 This Week in Cardiology
Obesity drugs as ASCVD-modifiers, HR monitors, when journals publish obvious facts, and effect scores and sorting out signals from RCTs are the topics John Mandrola, MD, covers in this week ' s podcast.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 22, 2024 Category: Cardiology Tags: Cardiology Commentary Source Type: news
Medicare can pay for obesity drugs like Wegovy in certain heart patients
Certain Medicare patients may get help paying for the popular weight-loss drug Wegovy, as long as they also have heart disease.#medicare (Source: Reuters: Health)
Source: Reuters: Health - March 21, 2024 Category: Consumer Health News Source Type: news
